Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Researchers discover hereditary protection a factor against depression

17.10.2006
Researchers from Umeå University, Sweden, in collaboration with Antwerp University, Belgium, have found a hereditary factor that is involved in the development of depression. Their study shows that a protein called TPH-2 plays a role in the development of both depression and manic depression.

The signal substance serotonin plays a significant role in brain functions. The level of serotonin in the brain has been shown to affect our emotions and moods.

The serotonin level in the brain is important in protecting against depression. Modern medicines for depression, so-called SSRI medicines (selective serotonin resorption inhibitors), work by raising the level of serotonin in the brain. The protein TPH-2 (brain-specific tryptophan hydroxylase), which is important for the regulation of the serotonin level in the brain, has long been suspected of playing a key role in the development of depression and manic depression.

The study, which was recently completed and is being published in the prestigious journal Archives of General Psychiatry, is based on an examination of what forms of TPH-2 (at the DNA level) are found in healthy individuals compared with the forms found in individuals with recurrent depression and manic depression, respectively.

The different forms of TPH-2 people inherit can result in differing levels of serotonin in the brain, thus providing varying degrees of protection against depression.

This comparison made it possible to show that the TPH-2 forms differed between healthy and affected individuals, which means that TPH-2 is involved in the development of these conditions. Certain forms were more common in healthy individuals, indicating that they have a protective effect against these conditions. There are as yet no clinical trials that have studied different THP-2 forms. All subjects who participated in the study live in northern Sweden.

The discovery of this hereditary protective factor, which is one of many, is a major piece of the puzzle in our understanding of the genesis and treatment of these disorders. Further research and economic resources are required for the discovery to lead to enhanced treatment and help for those affected.

The research has been carried out in a collaborative effort between a Swedish team of scientists under the direction of Professor Rolf Adolfsson and post-doctoral fellow Karl-Fredrik Norrback at the Research Unit of the Psychiatric Clinic in Umeå and the Department of Clinical Science, Section for Psychiatry, at Umeå University and a Belgian team of researchers from Antwerp University led by Professor Jurgen Del Favero and Ann van Den Boogaert, PhD. The study is being published in the prestigious journal Archives of General Psychiatry (Brain-specific tryptophan hydroxylase, TPH2, is associated with unipolar and bipolar disorder in a northern Swedish isolated population, 2006).

Depression is one of the most common disorders in the Western world, and according to the WHO (world Health Organization) it will be the most frequent disease by 2020. Three of ten Swedes experience depression some time during their lives, but it is still largely not known why. It is estimated that some 10 percent suffer from recurrent depression and an equally large group experience mood swings with varying degrees of manic depressive disease.

Despite the fact that these disorders cause a great deal of suffering, increased risk of suicide, and shortened lifetimes, as well as major socio-economic costs for society, the causes of these diseases are still largely a mystery. However, scientists agree that the conditions develop through a combination of heredity and environment, such as stress. Far too few research resources are still being allocated to scientists wishing to study mental health, even though the attitude toward research on mental health is improving.

Bertil Born | alfa
Further information:
http://www.umu.se

More articles from Health and Medicine:

nachricht Routing gene therapy directly into the brain
07.12.2017 | Boston Children's Hospital

nachricht New Hope for Cancer Therapies: Targeted Monitoring may help Improve Tumor Treatment
01.12.2017 | Berliner Institut für Gesundheitsforschung / Berlin Institute of Health (BIH)

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Scientists channel graphene to understand filtration and ion transport into cells

Tiny pores at a cell's entryway act as miniature bouncers, letting in some electrically charged atoms--ions--but blocking others. Operating as exquisitely sensitive filters, these "ion channels" play a critical role in biological functions such as muscle contraction and the firing of brain cells.

To rapidly transport the right ions through the cell membrane, the tiny channels rely on a complex interplay between the ions and surrounding molecules,...

Im Focus: Towards data storage at the single molecule level

The miniaturization of the current technology of storage media is hindered by fundamental limits of quantum mechanics. A new approach consists in using so-called spin-crossover molecules as the smallest possible storage unit. Similar to normal hard drives, these special molecules can save information via their magnetic state. A research team from Kiel University has now managed to successfully place a new class of spin-crossover molecules onto a surface and to improve the molecule’s storage capacity. The storage density of conventional hard drives could therefore theoretically be increased by more than one hundred fold. The study has been published in the scientific journal Nano Letters.

Over the past few years, the building blocks of storage media have gotten ever smaller. But further miniaturization of the current technology is hindered by...

Im Focus: Successful Mechanical Testing of Nanowires

With innovative experiments, researchers at the Helmholtz-Zentrums Geesthacht and the Technical University Hamburg unravel why tiny metallic structures are extremely strong

Light-weight and simultaneously strong – porous metallic nanomaterials promise interesting applications as, for instance, for future aeroplanes with enhanced...

Im Focus: Virtual Reality for Bacteria

An interdisciplinary group of researchers interfaced individual bacteria with a computer to build a hybrid bio-digital circuit - Study published in Nature Communications

Scientists at the Institute of Science and Technology Austria (IST Austria) have managed to control the behavior of individual bacteria by connecting them to a...

Im Focus: A space-time sensor for light-matter interactions

Physicists in the Laboratory for Attosecond Physics (run jointly by LMU Munich and the Max Planck Institute for Quantum Optics) have developed an attosecond electron microscope that allows them to visualize the dispersion of light in time and space, and observe the motions of electrons in atoms.

The most basic of all physical interactions in nature is that between light and matter. This interaction takes place in attosecond times (i.e. billionths of a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

See, understand and experience the work of the future

11.12.2017 | Event News

Innovative strategies to tackle parasitic worms

08.12.2017 | Event News

AKL’18: The opportunities and challenges of digitalization in the laser industry

07.12.2017 | Event News

 
Latest News

PhoxTroT: Optical Interconnect Technologies Revolutionized Data Centers and HPC Systems

11.12.2017 | Information Technology

Large-scale battery storage system in field trial

11.12.2017 | Power and Electrical Engineering

See, understand and experience the work of the future

11.12.2017 | Event News

VideoLinks
B2B-VideoLinks
More VideoLinks >>>